SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-050588
Filing Date
2023-06-21
Accepted
2023-06-21 17:00:20
Documents
6
Effectiveness Date
2023-06-21

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea180431-s8_relmadatherap.htm S-8 171103
2 OPINION OF SICHENZIA ROSS FERENCE LLP ea180431ex5-1_relmadatherap.htm EX-5.1 6117
3 CONSENT OF MARCUM LLP ea180431ex23-1_relmadatherap.htm EX-23.1 2175
4 FILING FEE TABLE ea180431ex-fee_relmadatherap.htm EX-FILING FEES 13672
5 GRAPHIC image_001.jpg GRAPHIC 5721
6 GRAPHIC ex5-1_001.jpg GRAPHIC 5325
  Complete submission text file 0001213900-23-050588.txt   209656
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272811 | Film No.: 231030639
SIC: 2834 Pharmaceutical Preparations